Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Will a digital boost keep Post-COVID recovery on track?

NCT ID NCT06124625

Disease control Sponsor: Schön Klinik Berchtesgadener Land Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial tests whether adding a 12-week digital maintenance program to standard inpatient rehabilitation helps people with post-COVID syndrome maintain improvements in quality of life and symptoms. Participants are randomly assigned to either rehabilitation alone or rehabilitation followed by the digital program, which includes physiotherapy, training, and psychological support. The study measures changes in quality of life, symptom intensity, and lung function over 19 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 12-week digital maintenance program (two 90-minute sessions per week) following a 3-week inpatient rehabilitation program
What this could lead to
If effective, this could offer a practical way to help people with post-COVID syndrome keep their rehabilitation gains longer, improving quality of life and daily functioning.
What could go wrong
The trial is relatively small and early, and the maintenance program may not provide lasting benefits beyond the initial rehabilitation. Digital access and adherence could also limit its effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Jan 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Post-COVID-syndrome (Definition WHO) * Entered the rehabilitation process at the Schoen Klinik Berchtesgadener Land Exclusion Criteria: * No internet access

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-COVID-19 syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

long COVID-19 post-COVID-19 disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-COVID-19 syndrome

Contacts and locations

Locations

  • Schone Klinik Berchtesgadener Land

    Schönau am Königssee, 83471, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.